z-logo
open-access-imgOpen Access
Formulation of New Intelligent Nanoparticle Inhibited H1N1 Influenza Subtype and SARS Coronavirus Type 2 (COVID-19) in vitro
Author(s) -
Nima Shirmohammadi,
Arefeh Khodaee,
Maryam Rahimi,
Marzieh Vanayi,
Reza Aghanouri
Publication year - 2021
Publication title -
biomedical and biotechnology research journal (bbrj)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.214
H-Index - 5
eISSN - 2588-9842
pISSN - 2588-9834
DOI - 10.4103/bbrj.bbrj_265_21
Subject(s) - virology , nanoparticle , in vitro , coronavirus , in silico , viability assay , chemistry , virus , amantadine , covid-19 , nanotechnology , biology , materials science , medicine , biochemistry , disease , pathology , gene , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom